Bank of Montreal’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Bank of Montreal’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-7,000	Closed	-$33K	–	4231
2015 Q1	$33K	Sell	7,000 -3,000	-30%	-$17.3K	﹤0.01%	3090
2014 Q4	$64K	Buy	+10,000	New	+$58.5K	﹤0.01%	2969
2014 Q3	–	Sell	-1,300	Closed	-$10K	–	4670
2014 Q2	$10K	Buy	+1,300	New	+$10.4K	﹤0.01%	3895

Other funds holding OCRX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Bank of Montreal's OCRX Position: Q2 2015 in Review

Bank of Montreal sold out of Ocera Therapeutics, Inc. (OCRX) in Q2 2015, closing a stake of 7,000 shares — an estimated $33K sold.

Bank of Montreal first reported a position in OCRX in Q2 2014 and held it in 3 quarters. The position peaked at $64K in Q4 2014. 32 funds tracked by Wall St. Rank hold OCRX as of Q2 2015.

Bank of Montreal reported no remaining Ocera Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
Bank of Montreal sold 7,000 Ocera Therapeutics, Inc. shares in Q2 2015, an estimated $33K.
Bank of Montreal first reported a position in Ocera Therapeutics, Inc. in Q2 2014 and held it in 3 quarters.
Bank of Montreal's Ocera Therapeutics, Inc. position peaked at $64K in Q4 2014.
32 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q2 2015.

Based on Bank of Montreal's 13F filing for Q2 2015, filed 4 Aug 2015.